Anti-GM1 and anti-sulfatide antibodies in polyneuropathies: Threshold titers and accuracy

Acta Neurologica Scandinavica

Volumn 103, Issue 3, 2001, Pages 180-187

  Isoardo, G ^a   Ferrero, B ^b   Barbero, P ^a   Cucci, A ^a   Oggero, A ^a   Pipieri, A ^c   Ricci, A ^a   Verdun, E ^a   Bergamasco, B ^a   Durelli, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b S GIOVANNI BOSCO HOSPITAL   (Italy)

^c NONE

Author keywords

Antibody; GM1; Paraproteinemia; Polyneuropathy; Sulfatide

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; SULFATIDE; SULFATIDE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHRONIC PAIN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MOTOR NEUROPATHY; PARAPROTEINEMIA; POLYNEUROPATHY;

AGED; ANTIBODY FORMATION; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GANGLIOSIDOSIS, GM1; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; POLYNEUROPATHIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SULFOGLYCOSPHINGOLIPIDS;

EID: 0035138598     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2001.103003180.x     Document Type: Article

References (29)

1. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
2. Results of testing for anti-GM1 antibodies
3. The clinical and diagnostic role of anti-GM1 antibody testing
4. Chronic motor neuropathies: Diagnosis, therapy and pathogenesis
5. The sensitivity and specificity of anti-GM1 antibody testing
6. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies
7. Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy
8. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome
9. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
10. The clinical correlates of high-titer IgG anti-GM1 antibodies
11. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein
12. Anti-sulfatide antibodies in neurological disease: Binding to rat dorsal root ganglia neurons
13. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy
14. Anti-sulfatide antibodies in peripheral neuropathy
15. Polyneuropathies associated with high titre anti-sulfatide antibodies: Characteristics of patients with and without serum monoclonal proteins
16. Anti-sulfatide antibodies in neuropathy. Clinical and electrophysiological correlate
17. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
18. Assessment of current diagnostic criteria for Guillain-Barré syndrome
19. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
20. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
21. Cryptogenetic partial epilepsies with anti-GM1 antibodies: A new form of immune-mediated epilepsy?
22. The use of relative operating characteristic (ROC) curves in test performance evaluation
23. Measuring the accuracy of diagnostic systems
24. Chronic idiopathic polyneuropathy presenting in middle or old age: A clinical and electrophysiological study of 75 patients
25. Antibody panels in idiopathic polyneuropathy and motor neuron disease
26. To test or not to test? That is the question
27. Testing for serum IgM binding to GM1 ganglioside in clinical practice
28. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis
29. Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases